S100A4 mRNA expression level is a predictor of radioresistance of pancreatic cancer cells

Oncology Reports

Volumn 30, Issue 4, 2013, Pages 1601-1608

  Kozono, Shingo ^a   Ohuchida, Kenoki ^a   Ohtsuka, Takao ^a   Cui, Lin ^a   Eguchi, Daiki ^a   Fujiwara, Kenji ^a   Zhao, Ming ^a   Mizumoto, Kazuhiro ^a,b   Tanaka, Masao ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

CDNA microarray; Pancreatic cancer cell line; Radioresistance; Radiosensitivity; S100 calcium binding protein A4

Indexed keywords

CALVASCULIN; CAVEOLIN 2; MESSENGER RNA;

ARTICLE; CANCER CELL CULTURE; CAVEOLIN 2 GENE; CELL STRAIN CAPAN 1; CELL STRAIN CFPAC 1; CONTROLLED STUDY; DNA MICROARRAY; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PHOSPHOPROTEIN ENRICHED IN ASTROCYTES 15 GENE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIATION RESPONSE; RADIOSENSITIVITY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; S100 CALCIUM BINDING PROTEIN A4 GENE; SURVIVAL RATE; TRANSMEMBRANE PROTEIN 158 GENE;

CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS; RADIATION TOLERANCE; RNA, MESSENGER; S100 PROTEINS;

EID: 84882673447     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2636     Document Type: Article

References (42)

1. Hariharan D, Saied A and Kocher HM: Analysis of mortality rates for pancreatic cancer across the world. HPB (Oxford) 10: 58-62, 2008.
2. Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236, 2011.
3. Johung K, Saif MW and Chang BW: Treatment of locally advanced pancreatic cancer: the role of radiation therapy. Int J Radiat Oncol Biol Phys 82: 508-518, 2012.
4. Wang F and Kumar P: The role of radiotherapy in management of pancreatic cancer. J Gastrointest Oncol 2: 157-167, 2011.
5. Golub TR, Slonim DK, Tamayo P, et al: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286: 531-537, 1999.
6. Ogawa K, Utsunomiya T, Mimori K, et al: Differential gene expression profiles of radioresistant pancreatic cancer cell lines established by fractionated irradiation. Int J Oncol 28: 705-713, 2006.
7. Moore PS, Sipos B, Orlandini S, et al: Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4. Virchows Arch 439: 798-802, 2001.
8. Gardner-Thorpe J, Ito H, Ashley SW and Whang EE: Differential display of expressed genes in pancreatic cancer cells. Biochem Biophys Res Commun 293: 391-395, 2002.
9. Gupta S, Sathishkumar S and Ahmed MM: Influence of cell cycle checkpoints and p53 function on the toxicity of temozolomide in human pancreatic cancer cells. Pancreatology 10: 565-579, 2010.
10. Ohuchida K, Mizumoto K, Murakami M, et al: Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. Cancer Res 64: 3215-3222, 2004.
11. Antonov J, Goldstein DR, Oberli A, et al: Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization. Lab Invest 85: 1040-1050, 2005.
12. Zhang L, Mizumoto K, Sato N, et al: Quantitative determination of apoptotic death in cultured human pancreatic cancer cells by propidium iodide and digitonin. Cancer Lett 142: 129-137, 1999.
13. Orre LM, Pernemalm M, Lengqvist J, Lewensohn R and Lehtiö J: Up-regulation, modification, and translocation of S100A6 induced by exposure to ionizing radiation revealed by proteomics profiling. Mol Cell Proteomics 6: 2122-2131, 2007.
14. Fukuda K, Sakakura C, Miyagawa K, et al: Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation. Br J Cancer 91: 1543-1550, 2004.
15. Hanna E, Shrieve DC, Ratanatharathorn V, et al: A novel alternative approach for prediction of radiation response of squamous cell carcinoma of head and neck. Cancer Res 61: 2376-2380, 2001.
16. Harima Y, Togashi A, Horikoshi K, et al: Prediction of outcome of advanced cervical cancer to thermoradiotherapy according to expression profiles of 35 genes selected by cDNA microarray analysis. Int J Radiat Oncol Biol Phys 60: 237-248, 2004.
17. Tewari D, Monk BJ, Al-Ghazi MS, et al: Gene expression profiling of in vitro radiation resistance in cervical carcinoma: a feasibility study. Gynecol Oncol 99: 84-91, 2005.
18. Wong YF, Sahota DS, Cheung TH, et al: Gene expression pattern associated with radiotherapy sensitivity in cervical cancer. Cancer J 12: 189-193, 2006.
19. Helland A, Johnsen H, Frøyland C, et al: Radiation-induced effects on gene expression: an in vivo study on breast cancer. Radiother Oncol 80: 230-235, 2006.
20. Otomo T, Hishii M, Arai H, Sato K and Sasai K: Microarray analysis of temporal gene responses to ionizing radiation in two glioblastoma cell lines: up-regulation of DNA repair genes. J Radiat Res 45: 53-60, 2004.
21. Jeong J, Hong SJ, Ju YJ, et al: Temporal cDNA microarray analysis of gene expression in human hepatocellular carcinoma upon radiation exposure. Oncol Rep 15: 33-48, 2006.
22. Kumagai K, Nimura Y, Mizota A, et al: Arpc1b gene is a candidate prediction marker for choroidal malignant melanomas sensitive to radiotherapy. Invest Ophthalmol Vis Sci 47: 2300-2304, 2006.
23. Xu QY, Gao Y, Liu Y, Yang WZ and Xu XY: Identification of differential gene expression profiles of radioresistant lung cancer cell line established by fractionated ionizing radiation in vitro. Chin Med J (Engl) 121: 1830-1837, 2008.
24. Lee YS, Oh JH, Yoon S, et al: Differential gene expression profiles of radioresistant non-small-cell lung cancer cell lines established by fractionated irradiation: tumor protein p53-inducible protein 3 confers sensitivity to ionizing radiation. Int J Radiat Oncol Biol Phys 77: 858-866, 2010.
25. Donato R: S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33: 637-668, 2001.
26. Tarabykina S, Kriajevska M, Scott DJ, et al: Heterocomplex formation between metastasis-related protein S100A4 (Mts1) and S100A1 as revealed by the yeast two-hybrid system. FEBS Lett 475: 187-191, 2000.
27. Helfman DM, Kim EJ, Lukanidin E and Grigorian M: The metastasis associated protein S100A4: role in tumour progression and metastasis. Br J Cancer 92: 1955-1958, 2005.
28. Ikenaga N, Ohuchida K, Mizumoto K, et al: S100A4 mRNA is a diagnostic and prognostic marker in pancreatic carcinoma. J Gastrointest Surg 13: 1852-1858, 2009.
29. Boye K and Maelandsmo GM: S100A4 and metastasis: a small actor playing many roles. Am J Pathol 176: 528-535, 2010.
30. Mishra SK, Siddique HR and Saleem M: S100A4 calcium-binding protein is key player in tumor progression and metastasis: preclinical and clinical evidence. Cancer Metastasis Rev 31: 163-172, 2012.
31. El-Deiry WS: The role of p53 in chemosensitivity and radiosensitivity. Oncogene 22: 7486-7495, 2003.
32. Bristow RG, Benchimol S and Hill RP: The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. Radiother Oncol 40: 197-223, 1996.
33. Li R, Sutphin PD, Schwartz D, et al: Mutant p53 protein expression interferes with p53-independent apoptotic pathways. Oncogene 16: 3269-3277, 1998.
34. Saintigny Y, Rouillard D, Chaput B, Soussi T and Lopez BS: Mutant p53 proteins stimulate spontaneous and radiation-induced intrachromosomal homologous recombination independently of the alteration of the transactivation activity and of the G1 checkpoint. Oncogene 18: 3553-3563, 1999.
35. Cadwell C and Zambetti GP: The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth. Gene 277: 15-30, 2001.
36. Williams JR, Zhang Y, Zhou H, et al: A quantitative overview of radiosensitivity of human tumor cells across histological type and TP53 status. Int J Radiat Biol 84: 253-264, 2008.
37. Grigorian M, Andresen S, Tulchinsky E, et al: Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J Biol Chem 276: 22699-22708, 2001.
38. Frazier MW, He X, Wang J, Gu Z, Cleveland JL and Zambetti GP: Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain. Mol Cell Biol 18: 3735-3743, 1998.
39. Ahmed KM and Li JJ: NF-κB-mediated adaptive resistance to ionizing radiation. Free Radic Biol Med 44: 1-13, 2008.
40. Dai Y, Lawrence TS and Xu L: Overcoming cancer therapy resistance by targeting inhibitors of apoptosis proteins and nuclear factor-kappa B. Am J Transl Res 1: 1-15, 2009.
41. Li F and Sethi G: Targeting transcription factor NF-κB to overcome chemoresistance and radioresistance in cancer therapy. Biochim Biophys Acta 1805: 167-180, 2010.
42. Boye K, Grotterød I, Aasheim HC, Hovig E and Maelandsmo GM: Activation of NF-κB by extracellular S100A4: analysis of signal transduction mechanisms and identification of target genes. Int J Cancer 123: 1301-1310, 2008.